A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

Michelle A FANALE; Andres FORERO-TORRES; Joseph D ROSENBLATT; Ranjana H ADVANI; AnnaR FRANKLIN; Dana A KENNEDY; Tae H HAN; Eric L SIEVERS; Nancy L BARTLETT

doi:10.1158/1078-0432.CCR-11-1425

$A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies$

Journal article

Open access

Peer reviewed

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

Michelle A FANALE, Andres FORERO-TORRES, Joseph D ROSENBLATT, Ranjana H ADVANI, AnnaR FRANKLIN, Dana A KENNEDY, Tae H HAN, Eric L SIEVERS and Nancy L BARTLETT

Clinical cancer research, Vol.18(1), pp.248-255

2012

DOI: https://doi.org/10.1158/1078-0432.CCR-11-1425

PMID: 22080439

Abstract

Biological and medical sciences

Medical sciences

Antineoplastic agents

Pharmacology. Drug treatments

Files and links (1)

url

https://doi.org/10.1158/1078-0432.CCR-11-1425View

Published (Version of record) Open

Metrics

4 Record Views

173 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.132 Lymphoma
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies
Creators: Michelle A FANALE - Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Andres FORERO-TORRES - University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Joseph D ROSENBLATT - Division of Hematology-Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, Florida, United States
Ranjana H ADVANI - Stanford University School of Medicine, Stanford Comprehensive Cancer Center, Stanford, California, United States
AnnaR FRANKLIN - Children's Cancer Hospital, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Dana A KENNEDY - Seattle Genetics, Bothell, Washington, United States
Tae H HAN - Seattle Genetics, Bothell, Washington, United States
Eric L SIEVERS - Seattle Genetics, Bothell, Washington, United States
Nancy L BARTLETT - Medical Oncology, Washington University, Siteman Cancer Center, St. Louis, Missouri, United States
Publication Details: Clinical cancer research, Vol.18(1), pp.248-255
Publisher: American Association for Cancer Research; Philadelphia, PA
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 22080439
Record Identifier: 991031575443302976